Bringing the Payer and Provider Perspectives Together: Dr. Lee Newcomer Shares His Unique Take on Precision Oncology

Bringing the Payer and Provider Perspectives Together: Dr. Lee Newcomer Shares His Unique Take on Precision Oncology

Publication date: May 12, 2019

How precision medicine is moving oncologists away from population-based treatments to more patient-appropriate care. Dr. Lee Newcomer, board-certified oncologist and former SVP of oncology and genetics at UnitedHealthcare, answers pressing questions about the current costs of cancer care, how diagnostics are currently reimbursed and who should control the development of those diagnostics. His answers gave us a lot to think about.

Concepts Keywords
Board Certified Cancer care
Oncologist Cancer
SVP Evidence-based medicine
UnitedHealthcare Precision medicine
Systems biology

Semantics

Type Source Name
disease MESH cancer
disease DOID cancer
disease MESH development

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *